Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Circulation|September 1, 1990
Activation and decreased deformability of neutrophils after intermittent claudicationF J Neumann, W Waas, C Diehm, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
[Development of an illness-specific instrument for assessment of quality of life in patients with arterial occlusive disease (Peripheral Arterial Occlusive Disease 86 Questionnaire)]M Bullinger, M Cachovan, A Creutzig, et al.
Medizinische Klinik (Munich, Germany : 1983)|December 15, 1995
[Quality of life in peripheral arterial occlusive disease. Multicenter study of quality of life characteristics with a newly developed disease-specific questionnaire]H Heidrich, M Bullinger, M Cachovan, et al.
Der Internist|August 31, 2010
[Anticoagulation in the elderly]J Harenberg, R Bauersachs, C Diehm, et al.
European Journal of Clinical Investigation|August 20, 2003
Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross-sectional study of 6880 primary care patientsH Darius, D Pittrow, R Haberl, et al.
International Angiology : a Journal of the International Union of Angiology|October 1, 1991
Reduction of ischaemic rest pain in advanced peripheral arterial occlusive disease. A double blind placebo controlled trial with iloprostK Balzer, G Bechara, H Bisler, et al.
Schweizerische Medizinische Wochenschrift|October 6, 1990
[Iloprost in the treatment of ischemic tissue lesions in diabetics. Results of a placebo-controlled multicenter study with a stable prostacyclin derivative]F E Brock, O Abri, G Baitsch, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|June 18, 2010
The next 10 years in the management of peripheral artery disease: perspectives from the 'PAD 2009' ConferenceL Norgren, W R Hiatt, J A Dormandy, et al.
Deutsche Medizinische Wochenschrift (1946)|December 26, 2006
[Metabolic syndrome and peripheral arterial occlusive disease as indicators for increased cardiovascular risk]C Diehm, H Darius, D Pittrow, et al.
VASA. Supplementum|January 1, 1989
Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter studyG Trübestein, S von Bary, K Breddin, et al.
Pageof 10